Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
The financially motivated cybercriminal threat actor Storm-1175 operates high-velocity ransomware campaigns that weaponize ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果